Q2 2014 Holdings
Filed 2014-08-14 | 38 holdings | $224.8K | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $22.4K | 1,512,103 | 10.0% |
| Hyperion Therapeutics Inc | COM | 44915N101 | $17.2K | 657,984 | 7.6% |
| Derma Sciences Inc | COM PAR $.01 | 249827502 | $13.3K | 1,148,292 | 5.9% |
| Thoratec Corp | COM NEW | 885175307 | $12.6K | 360,000 | 5.6% |
| Infinity Pharmaceuticals Inc(INFIQ) | COM | 45665G303 | $12.2K | 958,600 | 5.4% |
| Orthofix Intl N V | COM | N6748L102 | $10.9K | 300,700 | 4.8% |
| Ophthotech Corp | COM | 683745103 | $10.6K | 250,100 | 4.7% |
| Pain Therapeutics Inc | COM | 69562K100 | $9.7K | 1,694,256 | 4.3% |
| Alimera Sciences Inc | COM | 016259103 | $9.6K | 1,610,316 | 4.3% |
| Aradigm Corp(ARDMEUR) | COM NO PAR NEW | 038505400 | $8.9K | 1,008,062 | 4.0% |
| Oxygen Biotherapeutics Inc | COM PAR $0.0001 | 69207P308 | $8.6K | 2,115,497 | 3.8% |
| Veracyte Inc(VCYT) | COM | 92337F107 | $7.9K | 461,210 | 3.5% |
| Oncogenex Pharmaceutical in | COM | 68230A106 | $7.9K | 2,111,590 | 3.5% |
| Ambit Biosciences Corp | COM | 02318X100 | $7.3K | 1,053,895 | 3.2% |
| Alcobra LTD | SHS | M2239P109 | $5.8K | 332,908 | 2.6% |
| Anthera Pharmaceuticals Inc | COM NEW | 03674U201 | $5.1K | 1,500,000 | 2.3% |
| Exact Sciences Corp(EXAS)Put | COM | 30063P105 | $4.3K | 250,900 | 1.9% |
| Aveo Pharmaceuticals Inc(AVEOEUR) | COM | 053588109 | $4.3K | 2,325,000 | 1.9% |
| Recro Pharma Inc | COM | 75629F109 | $4.2K | 520,776 | 1.9% |
| Volcano Corporation | COM | 928645100 | $4.1K | 232,645 | 1.8% |
| Sophiris BIO Inc | COM NEW | 83578Q209 | $3.6K | 1,585,500 | 1.6% |
| Karyopharm Therapeutics Inc(KPTIEUR) | COM | 48576U106 | $3.5K | 75,000 | 1.6% |
| Cara Therapeutics Inc(CARAEUR) | COM | 140755109 | $3.4K | 200,219 | 1.5% |
| Cutera Inc(CUTREUR) | COM | 232109108 | $3.2K | 303,713 | 1.4% |
| Endologix Inc | COM | 29266S106 | $2.9K | 193,282 | 1.3% |
| Oncothyreon Inc | COM | 682324108 | $2.6K | 791,800 | 1.1% |
| Vical Inc | COM | 925602104 | $2.6K | 2,090,954 | 1.1% |
| Avanir Pharmaceuticals Inc | CL A NEW | 05348P401 | $2.5K | 450,000 | 1.1% |
| Sunshine Heart Inc | COM | 86782U106 | $2.4K | 424,208 | 1.1% |
| Ocera Therapeutics Inc | COM | 67552A108 | $2.3K | 296,944 | 1.0% |
| Kalobios Pharmaceuticals Inc | COM | 48344T100 | $2.1K | 910,699 | 0.9% |
| Psivida Corp | COM | 74440J101 | $1.6K | 379,060 | 0.7% |
| Inovio Pharmaceuticals IncPut | COM NEW | 45773H201 | $1.4K | 126,000 | 0.6% |
| Dipexium Pharmaceuticals Inc | COM | 25456J104 | $1.2K | 124,125 | 0.5% |
| MEI Pharma Inc | COM NEW | 55279B202 | $1.0K | 157,661 | 0.4% |
| Streamline Health Solutions | COM | 86323X106 | $728 | 151,611 | 0.3% |
| Protalix Biotherapeutics Inc | COM | 74365A101 | $612 | 167,787 | 0.3% |
| Onconova Therapeutics Inc | COM | 68232V108 | $594 | 109,449 | 0.3% |